APA (7th ed.) Citation

A, Ò., L, M., F, B., E, G., E, C., C, M., . . . V, S. (2025). Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenografts. NPJ precision oncology, 9(1), 393. https://doi.org/10.1038/s41698-025-01172-5

Chicago Style (17th ed.) Citation

A, Òdena, et al. "Determinants of Long-term Response to Patritumab Deruxtecan in Breast Cancer Patient-derived Xenografts." NPJ Precision Oncology 9, no. 1 (2025): 393. https://doi.org/10.1038/s41698-025-01172-5.

MLA (9th ed.) Citation

A, Òdena, et al. "Determinants of Long-term Response to Patritumab Deruxtecan in Breast Cancer Patient-derived Xenografts." NPJ Precision Oncology, vol. 9, no. 1, 2025, p. 393, https://doi.org/10.1038/s41698-025-01172-5.